Genoptix is a part of Novartis Molecular Diagnostics (MDx), a unit within the Novartis Pharmaceuticals Division. We are focused on developing and commercializing evidence-driven diagnostic tests to improve physicians’ ability to optimize patient outcomes.

We provide personalized and comprehensive laboratory services to community-based hematologists and oncologists, specializing in diagnosing cancers and disorders in bone marrow, blood, and lymph nodes, with expertise in the most challenging diagnoses. We also specialize in solid tumor workups using molecular testing.